Galectin Therapeutics (GALT) Return on Assets (2011 - 2026)
Galectin Therapeutics' quarterly Return on Assets came in at 0.01% in Q1 2026, up 2.0% year-on-year from 0.01% in Q1 2025, and up 20.23% quarter-over-quarter from 0.02% in Q4 2025.
Galectin Therapeutics has reported Return on Assets for 16 years, with the latest figure at 0.01% in Q1 2026.
- For the quarter ending Q1 2026, Return on Assets rose 2.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (up 2.0% YoY), and the FY2025 full-year result was 0.01%, up 1.0% from the prior year.
- Return on Assets for Q1 2026 stood at 0.01%, up from 0.02% in the prior quarter.
- The five-year high for Return on Assets was 0.01% in Q1 2022, with the low at 0.03% in Q1 2025.
- Average Return on Assets over 5 years is 0.02%, with a median of 0.02% recorded in 2025.
- Year-over-year, Return on Assets decreased 2 bps in 2025 and climbed 2 bps in 2026.
- Tracing GALT's Return on Assets over 5 years: stood at 0.02% in 2022, then advanced by 20 bps to 0.02% in 2023, then fell by 27 bps to 0.02% in 2024, then gained by 18 bps to 0.02% in 2025, then grew by 20 bps to 0.01% in 2026.
- The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.02% (Q4 2025), and 0.03% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -0.01% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.00% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.03% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.03% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |
| Mar 31, 2021 | -0.01% |
| Dec 31, 2020 | -0.01% |
| Sep 30, 2020 | -0.01% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | -0.01% |
| Dec 31, 2018 | -0.01% |
| Sep 30, 2018 | -0.01% |
| Jun 30, 2018 | -0.02% |
| Mar 31, 2018 | -0.03% |
| Dec 31, 2017 | -0.03% |
| Sep 30, 2017 | -0.02% |
| Jun 30, 2017 | -0.02% |
| Mar 31, 2017 | -0.01% |
| Dec 31, 2016 | -0.01% |
| Sep 30, 2016 | -0.01% |
| Jun 30, 2016 | -0.01% |
| Mar 31, 2016 | -0.01% |
| Dec 31, 2015 | -0.01% |
| Sep 30, 2015 | -0.01% |
| Jun 30, 2015 | -0.01% |
| Mar 31, 2015 | -0.01% |
| Dec 31, 2014 | -0.01% |
| Sep 30, 2014 | 0.00% |
| Jun 30, 2014 | 0.00% |
| Mar 31, 2014 | -0.01% |
| Dec 31, 2013 | -0.01% |
| Sep 30, 2013 | -0.02% |
| Jun 30, 2013 | -0.02% |
| Mar 31, 2013 | -0.01% |
| Dec 31, 2012 | -0.01% |
| Sep 30, 2012 | -0.01% |
| Jun 30, 2012 | -0.01% |
| Mar 31, 2012 | -0.01% |
| Dec 31, 2011 | -0.01% |
| Sep 30, 2011 | -0.01% |